Supernus, Inc. (SUPN) income statement
SUPNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$39.84+1.96 (+5.17%)
Close on Oct 19, 2026Market cap $4.86BP/E 11.2Yield –
Supernus, Inc. financial ratios
See a number that looks wrong?
Close on Oct 19, 2026Market cap $4.86BP/E 11.2Yield –
See a number that looks wrong?
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Margins | ||||||
| Gross margin | 80.2% | 80.6% | 84.1% | 83.1% | 83.9% | – |
| Operating margin | 21.1% | 3.2% | -13.9% | -8.5% | 26.9% | – |
| EBITDA margin | 22.0% | 4.5% | -12.5% | -6.8% | 28.8% | – |
| Pre-tax margin | 19.3% | 1.7% | -13.3% | -9.5% | 24.0% | – |
| Net profit margin | 16.9% | 0.59% | -11.5% | -4.7% | – | – |
| Free cash flow margin | -7.5% | 0.59% | -28.2% | -1.00% | 44.1% | – |
| Effective tax rate | 12.1% | 65.0% | – | – | -7.9% | – |
| Returns on capital | ||||||
| Return on equity | -96.6% | -2.7% | 126.6% | -79.2% | – | – |
| Return on assets | 16.7% | 0.46% | -7.1% | -2.3% | – | – |
| Return on tangible assets | 16.7% | 0.46% | -7.2% | -2.3% | – | – |
| Return on invested capital | -154.5% | -4.5% | 26.7% | 9.4% | -28.8% | – |
| Return on capital employed | 77.2% | 8.7% | -24.8% | -8.7% | 20.7% | – |
| Return on total capital | 241.5% | 138.2% | -107.0% | -26.2% | 58.7% | – |
| NOPAT | $230.21M | $15.20M | -$120.08M | -$60.83M | $213.00M | – |
| Cash flow quality | ||||||
| OCF / Sales | -2.2% | 3.0% | -27.4% | -0.44% | 44.6% | – |
| OCF / Net income | -0.13 | 5.14 | 2.38 | 0.10 | – | – |
| FCF / OCF | 344.4% | 19.4% | 102.7% | 225.0% | 98.9% | – |
| FCF / Net income | -0.44 | 1.00 | 2.44 | 0.21 | – | – |
| FCF / EBITDA | -34.2% | 13.0% | 224.8% | 14.8% | 153.1% | – |
| Unlevered free cash flow | -$57.45M | $39.39M | -$280.35M | $12.33M | $370.33M | – |
| Levered free cash flow | -$93.00M | $7.00M | -$308.00M | -$9.00M | $349.00M | – |
| Efficiency | ||||||
| Asset turnover | 0.98 | 0.77 | 0.62 | 0.50 | 0.43 | – |
| Fixed asset turnover | 10.16 | 12.91 | 15.84 | 16.09 | 13.64 | – |
| Receivables turnover | 4.89 | 4.68 | 4.61 | 4.27 | 3.92 | – |
| Days sales outstanding | 74.7 | 78.0 | 79.1 | 85.5 | 93.2 | – |
| Payables turnover | 4.43 | 1.79 | 0.43 | 0.23 | 0.18 | – |
| Days payables outstanding | 82.3 | 203.8 | 851.7 | 1,615.9 | 2,069.3 | – |
| Inventory turnover | 1.54 | 1.58 | 1.45 | 1.44 | 1.34 | – |
| Days inventory outstanding | 237.4 | 231.5 | 251.7 | 252.6 | 273.0 | – |
| Operating cycle | 312.1 | 309.5 | 330.9 | 338.1 | 366.2 | – |
| Cash conversion cycle | 229.7 | 105.7 | -520.8 | -1,277.8 | -1,703.0 | – |
| CapEx to revenue | 5.3% | 2.4% | 0.73% | 0.55% | 0.51% | – |
| CapEx to OCF | -244.4% | 80.6% | -2.7% | -125.0% | 1.1% | – |
| CapEx to depreciation | 6.60 | 1.81 | 0.53 | 0.31 | 0.27 | – |
| Liquidity | ||||||
| Current ratio | 0.71 | 0.90 | 0.98 | 1.24 | 1.80 | – |
| Quick ratio | 0.55 | 0.71 | 0.88 | 1.12 | 1.68 | – |
| Cash ratio | 0.21 | 0.35 | 0.32 | 0.76 | 1.37 | – |
| Working capital | -$262.00M | -$97.00M | -$24.00M | $240.00M | $640.00M | – |
| Net current asset value | -$648.00M | -$825.00M | -$685.00M | -$459.00M | -$185.00M | – |
| Leverage | ||||||
| Total debt | $319.00M | $333.00M | $243.00M | $240.00M | $242.00M | – |
| Net debt | $124.00M | $13.00M | -$167.00M | -$534.00M | -$860.00M | – |
| Debt / Equity | -3.26 | -0.99 | -1.32 | -16.00 | 2.00 | – |
| Debt ratio | 26.6% | 25.3% | 13.8% | 13.6% | 13.2% | – |
| Assets to equity | -12.26 | -3.91 | -9.55 | -117.93 | 15.14 | – |
| Long-term debt to assets | 24.1% | 23.9% | 13.5% | 13.4% | 13.0% | – |
| Long-term debt to equity | -2.96 | -0.93 | -1.29 | -15.80 | 1.98 | – |
| Total debt / Capitalization | 144.3% | -8,325.0% | 411.9% | 106.7% | 66.7% | – |
| Long-term debt / Capitalization | 151.0% | -1,431.8% | 447.2% | 106.8% | 66.4% | – |
| Net debt / EBITDA | 0.46 | 0.24 | 1.22 | 8.75 | -3.77 | – |
| Total debt / EBITDA | 1.17 | 6.17 | -1.77 | -3.93 | 1.06 | – |
| Cash flow to debt | -8.5% | 10.8% | -123.5% | -1.7% | 145.9% | – |
| Goodwill / Assets | 0.17% | 0.15% | 0.28% | – | – | – |
| Intangibles to total assets | 0.17% | 0.15% | 0.28% | – | – | – |
| Interest coverage | ||||||
| EBIT / Interest expense | 5.82 | 0.93 | -4.34 | -2.85 | 7.89 | – |
| EBITDA / Interest expense | 6.04 | 1.32 | -3.91 | -2.26 | 8.44 | – |
| (EBITDA − CapEx) / Interest expense | 4.58 | 0.61 | -4.14 | -2.44 | 8.30 | – |
| Per share | ||||||
| Revenue per share | 9.68 | 8.93 | 7.98 | 6.48 | 5.21 | – |
| EPS (basic) | 1.68 | 0.05 | -0.92 | -0.30 | – | – |
| EPS (diluted) | 1.64 | 0.05 | -0.92 | -0.30 | – | – |
| Book value per share | -0.77 | -2.53 | -1.34 | -0.11 | 0.80 | – |
| Tangible book value per share | -0.78 | -2.55 | -1.38 | -0.11 | 0.80 | – |
| Cash per share | 1.52 | 2.41 | 2.99 | 5.57 | 7.25 | – |
| Operating cash flow per share | -0.21 | 0.27 | -2.19 | -0.03 | 2.32 | – |
| Free cash flow per share | -0.73 | 0.05 | -2.25 | -0.06 | 2.30 | – |
| CapEx per share | 0.52 | 0.22 | 0.06 | 0.04 | 0.03 | – |
| Valuation at period end | ||||||
| Market cap | $4.57B | $1.70B | $2.12B | $3.30B | – | – |
| Enterprise value | $4.45B | $1.54B | $1.59B | $2.44B | – | – |
| P/E | 21.8x | 243x | – | – | – | – |
| P/S | 3.7x | 1.4x | 1.9x | 3.7x | – | – |
| P/B | -46.7x | -5.1x | -11.5x | -220x | – | – |
| P/TBV | -45.7x | -5.0x | -11.2x | -220x | – | – |
| P/Gross profit | 4.6x | 1.8x | 2.3x | 4.4x | – | – |
| P/OCF | -169x | 47.3x | -7.1x | -826x | – | – |
| P/FCF | – | 243x | – | – | – | – |
| EV/Sales | 3.6x | 1.3x | 1.5x | 2.7x | – | – |
| EV/Gross profit | 4.5x | 1.6x | 1.7x | 3.3x | – | – |
| EV/EBITDA | 16.4x | 28.4x | – | – | – | – |
| EV/EBIT | 17.0x | 40.4x | – | – | – | – |
| EV/OCF | -165x | 42.7x | -5.3x | -611x | – | – |
| EV/FCF | – | 219x | – | – | – | – |
| Earnings yield | 4.6% | 0.41% | -5.9% | -1.3% | – | – |
| FCF yield | -2.0% | 0.41% | -14.5% | -0.27% | – | – |
| Shareholder yield | ||||||
| Buyback yield | 0.20% | 10.0% | 1.4% | 2.7% | – | – |
| Debt paydown yield | 0.37% | 14.1% | 0.57% | 0.09% | – | – |
| Shareholder yield | 0.20% | 10.0% | 1.4% | 2.7% | – | – |
| Cost structure | ||||||
| R&D to revenue | 7.8% | 9.0% | 10.6% | 8.2% | 6.6% | – |
| SG&A to revenue | 51.2% | 51.5% | 51.7% | 51.7% | 54.5% | – |
| Stock-based comp to revenue | 2.1% | 2.0% | 1.9% | 1.8% | 1.4% | – |
| Per employee | ||||||
| Total employees | 838 | 1,051 | 1,164 | 1,164 | 1,164 | 1,164 |
| Revenue per employee | $1.48M | $1.13M | $939.00K | $774.05K | $679.55K | – |
| Gross profit per employee | $1.19M | $910.56K | $789.52K | $643.47K | $570.45K | – |
| Operating profit per employee | $312.65K | $36.16K | -$130.58K | -$66.15K | $182.99K | – |
| Net income per employee | $250.60K | $6.66K | -$108.25K | -$36.08K | – | – |
| Free cash flow per employee | -$110.98K | $6.66K | -$264.60K | -$7.73K | $299.83K | – |
| Growth | ||||||
| Revenue 1Y growth | 4.3% | 8.7% | 21.3% | 13.9% | – | – |
| Revenue 3Y CAGR | 11.2% | 14.5% | – | – | – | – |
| Gross profit 1Y growth | 3.9% | 4.1% | 22.7% | 12.8% | – | – |
| Gross profit 3Y CAGR | 9.9% | 13.0% | – | – | – | – |
| EBIT 1Y growth | 589.5% | 125.0% | -97.4% | -136.2% | – | – |
| EBIT 3Y CAGR | – | -43.7% | – | – | – | – |
| EBITDA 1Y growth | 403.7% | 139.4% | -124.6% | -126.8% | – | – |
| EBITDA 3Y CAGR | – | -38.1% | – | – | – | – |
| Net income 1Y growth | 2,900.0% | 105.6% | -200.0% | – | – | – |
| Diluted EPS 1Y growth | 3,180.0% | 105.4% | -206.7% | – | – | – |
| Operating cash flow 1Y growth | -175.0% | 112.0% | -7,400.0% | -101.1% | – | – |
| Operating cash flow 3Y CAGR | – | -53.3% | – | – | – | – |
| Free cash flow 1Y growth | -1,428.6% | 102.3% | -3,322.2% | -102.6% | – | – |
| Free cash flow 3Y CAGR | – | -72.8% | – | – | – | – |
| CapEx 1Y growth | 127.6% | 262.5% | 60.0% | 25.0% | – | – |
| CapEx 3Y CAGR | 136.3% | 93.5% | – | – | – | – |
| Total assets 1Y growth | -8.7% | -25.1% | -0.62% | -3.4% | – | – |
| Total assets 3Y CAGR | -12.1% | -10.4% | – | – | – | – |
| Total equity 1Y growth | 70.9% | -83.2% | -1,126.7% | -112.4% | – | – |
Every figure here is calculated from standardized financial statements — hover a row name for the formula — not reported by the company. Valuation multiples use the closing price at the end of that period, not today's price.